StreetAlpha.app
Home › Stocks › XTNT

Xtant Medical Holdings, Inc. (XTNT)

$0.21
▼ −5.95%
LAST CLOSE · NOV 17

Xtant Medical makes bone graft materials and spinal implant systems for spine surgeons and hospitals. It last closed at $0.21 on Nov 17, down 5.95% on the day.

AI Auto Pilots
Is XTNT in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$100.6M
−24.4% vs a year ago
Net income
−$16.0M
−1014.2% vs a year ago
EPS (diluted)
−$0.11
−1200.0% vs a year ago
Free cash flow
−$6.1M
−6.1% margin
Valuation
Market cap
$29.1M
140.5M shares
P/E
–
No P/E while losing money
Price to sales
0.3
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$7.8M
At Sep 30
Debt
$5.4M
At Sep 30
Shareholder equity
$37.3M
Shares outstanding
140.5M
At Nov 13
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $55.3M$55.3MFY2021FY2022: $58.0M$58.0MFY2022FY2023: $91.3M$91.3MFY2023FY2024: $117.3M$117.3MFY2024FY2025: $133.9M$133.9MFY2025

From XTNT's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 16). Last 12 months adds up the four latest quarters.

Last report
Nov 16
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated XTNT in the past 90 days, not enough for a consensus
Average 12-month target
$1.00
▲ 383.3% upside

Based on 1 analyst who set a price target on XTNT in the past 90 days. The average target is $1.00, with a high of $1.00 and a low of $1.00, compared with the last close of $0.21.

Low $1.00Avg $1.00High $1.00
Blue marker: last close $0.21
Highest target$1.00
Average target$1.00
Lowest target$1.00
Latest rating changes
LUCID CAPITAL MARKETSInitiated
Sep 2Buy$1
DateFirmActionRatingPrice target
Sep 2LUCID CAPITAL MARKETSInitiatedBuy$1
Loading…

Technical Analysis

XTNT · as of the Nov 17 close · updated after every close
Downtrend, oversold

The stock is 34% below its 20 day and 50% below its 50 day average. It is 113% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 22), oversold. The nearest support is the Pivot S1 at $0.20, and the nearest resistance the Pivot at $0.21.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 13.7%/day
Key levels
$0.8452 week high+300.0%
$0.44200 day average+109.5%
$0.35100 day average+66.7%
$0.32Swing high (Oct 22)+52.4%
$0.3150 day average+47.6%
$0.2820 day average+33.3%
$0.22Pivot R1+4.8%
$0.21Pivot+0.0%
$0.21Last close
$0.20Pivot S1−4.8%
$0.1752 week low−19.0%
Indicators
RSI (14)21.51Oversold below 30Oversold
MACD-0.02Below its signal lineBearish
Stochastic24.2Middle of its rangeNeutral
ADX (14)20.9Weak trend
Williams %R-76.9Oversold below −80, overbought above −20Neutral
CCI (20)-326.6Oversold below −100, overbought above 100Oversold
Rate of change−28.6%Change over 10 sessionsBearish
ATR (14)$0.03Typical daily range, 13.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for XTNT

What happened before

See how XTNT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow XTNT usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How XTNT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2010.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in XTNT in the last 90 days.

Loading…

See today’s whale options flow across the market →

XTNT Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bearish
Strongly bearishNeutralStrongly bullish
  • ▼9 buying vs 13 selling
  • ▼Held by funds -49.4 pts
  • ▼Funds holding -1
  • ▼Superinvestors: 0 added, 3 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding3233−3.0%
In funds' top 1000–
Held by funds56.5%105.9%−49.4 pts
New / increased6 / 36 / 7−30.8%
Reduced / sold out5 / 83 / 7+30.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See XTNT institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether XTNT is in one of them and how their past XTNT trades turned out.

XTNT in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered XTNT in an article yet. Here's the latest on the wider market.

About Xtant Medical Holdings

Xtant Medical makes orthobiologics, which are bone graft materials, along with spinal implant fixation systems used in spinal fusion surgery. Its products include human bone allografts, synthetic bone graft substitutes, and amniotic membrane allografts for wound care. Orthopedic spine surgeons and neurosurgeons are the main users, and the company sells mostly in the United States through independent agents and distributors, with some sales in Europe, Canada, Mexico, South America, and parts of the Pacific region. The company is based in Belgrade, Montana.

Headquarters
Belgrade, MT
Founded
2006